FENTANYL
Ahwatukee Behavioral Health & Wellness provides MAT to all qualified clients when deemed medically appropriate by our providers and is offered as a part of a holistic treatment plan to promote abstinence from drugs, alcohol, and other substances of abuse. Ahwatukee Behavioral Health & Wellness offers FDA-approved medications for MAT and evidence-based practices to treat substance abuse and promote abstinence. Our medical providers make a concerted effort to educate clients on the benefits of MAT and provide strong encouragement to engage in MAT to support ongoing abstinence.
Clonidine: A medication used to lessen the moderate symptoms of opioid withdrawal, including sweating, vomiting, chills, and insomnia.
Buprenorphine: An FDA-approved partial opiate antagonist medication used for mild-to-severe opioid use disorder that controls cravings and lessens withdrawal symptoms.
Methadone: A long-acting, full opioid agonist medication used to stabilize and maintain people in recovery from opioid use disorder (OUD).
-
For the management of acute alcohol withdrawal, benzodiazepines are commonly administered for seizure prophylaxis and other symptomatic management, before being tapered off throughout the detox period.
- With some types of benzodiazepine dependence, a relatively long-acting benzodiazepine (e.g., diazepam, chlordiazepoxide) will first be substituted for the benzodiazepine having been previously used. Then, it will be tapered slowly to ease withdrawal over a more extended amount of time.